pharma · MAC Lung Disease · Mycobacterium Abscessus Infection · ANTX
AN2 Therapeutics
AN2 Therapeutics clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Menlo Park, USA HQ
2019 Founded
35 Employees
Public company Type
ANTX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Menlo Park, USA
- Founded
- 2019
- Employees
- 35
- Programs
- 6
- Drugs
- 2
- Patents
- 0
AN2 Therapeutics projects
0 ClinicalTrials.gov programs sponsored by AN2 Therapeutics.
AN2 Therapeutics has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
No programs matched
Frequently asked questions
How many clinical projects does AN2 Therapeutics have?
0 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.